Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 28 January 2020
International variations in ovarian cancer survival by stage were observed, with the largest differences for those in the oldest age group with advanced disease.
Published date 13 January 2020
Children treated for renal malignancies in Australia have excellent long-term survival, which is unchanged since 1983.
Published date 13 January 2020
Cure models provide unique insights into whether survival improvements are due to prolonging life or through curing the disease.
Published date 07 January 2020
Lung cancers in children under the age of 15 are very uncommon, detection can be difficult due to the rarity of the disease and generally non-specific symptoms.
Published date 30 December 2019
We considered the weight of evidence method to be most suitable for population-level reporting of cancer incidence among Aboriginal people.
Published date 26 December 2019
Source:
Med J Aust , 212 (3), 113-120
The incidence rates of several childhood cancer types steadily increased during 1983-2015.
Published date 19 December 2019
Source:
Med J Aust , 212 (4), 163-168
About 11,000 cancers in women & 18,000 in men may be overdiagnosed each year. See more on estimating the magnitude of cancer overdiagnosis in Australia.
Published date 16 December 2019
Source:
Cancer Epidemiol , 64, 101659
Find out how qualitative research of barriers to screening may provide insight into how BreastScreen participation rate may be increased across Australia.
Published date 15 December 2019
Source:
BMJ Open , 9 (12), e031874
Significant differences in the burden of cancer persist across socioeconomic strata in Australia.
Published date 28 November 2019
Source:
Breast Cancer Res , 21 (1), 128
We found no overall association of smoking or alcohol consumption with breast cancer risk, but differences in risk were observed when familial risk profiles and estrogen receptor status were taking into consideration.
